LINC01094 facilitates ccRCC radioresistance by targeting miR-577/CHEK2/FOXM1 axis, blazing a new trail for overcoming radioresistance in ccRCC. This evidence concerns the gene CHEK2 and nonpapillary renal cell carcinoma.